These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18458227)

  • 1. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations.
    Nicholson GA; Magdelaine C; Zhu D; Grew S; Ryan MM; Sturtz F; Vallat JM; Ouvrier RA
    Neurology; 2008 May; 70(19):1678-81. PubMed ID: 18458227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene.
    Lawson VH; Graham BV; Flanigan KM
    Neurology; 2005 Jul; 65(2):197-204. PubMed ID: 16043786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
    Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
    Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations.
    Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C
    Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitofusin 2 gene mutation (R94Q) causing severe early-onset axonal polyneuropathy (CMT2A).
    Neusch C; Senderek J; Eggermann T; Elolff E; Bähr M; Schneider-Gold C
    Eur J Neurol; 2007 May; 14(5):575-7. PubMed ID: 17437620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy and 46XY gonadal dysgenesis: a heterogeneous entity.
    Baets J; Dierick I; Groote CC; Ende Jv; Martin JJ; Geens K; Robberecht W; Nelis E; Timmerman V; Jonghe PD
    Neuromuscul Disord; 2009 Feb; 19(2):172-5. PubMed ID: 19167223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.
    Züchner S; De Jonghe P; Jordanova A; Claeys KG; Guergueltcheva V; Cherninkova S; Hamilton SR; Van Stavern G; Krajewski KM; Stajich J; Tournev I; Verhoeven K; Langerhorst CT; de Visser M; Baas F; Bird T; Timmerman V; Shy M; Vance JM
    Ann Neurol; 2006 Feb; 59(2):276-81. PubMed ID: 16437557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease and clinical features of mutations of the gene for mitofusin 2: an important cause of hereditary peripheral neuropathy with striking clinical variability in children and adults.
    Ouvrier R; Grew S
    Dev Med Child Neurol; 2010 Apr; 52(4):328-30. PubMed ID: 20163430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.
    Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C
    Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic variability in giant axonal neuropathy.
    Tazir M; Nouioua S; Magy L; Huehne K; Assami S; Urtizberea A; Grid D; Hamadouche T; Rautenstrauss B; Vallat JM
    Neuromuscul Disord; 2009 Apr; 19(4):270-4. PubMed ID: 19231187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular genetics of inherited neuropathies].
    Takashima H
    Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic spectrum of MFN2 mutations in the Spanish population.
    Casasnovas C; Banchs I; Cassereau J; Gueguen N; Chevrollier A; Martínez-Matos JA; Bonneau D; Volpini V
    J Med Genet; 2010 Apr; 47(4):249-56. PubMed ID: 19889647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies.
    Li J; Ghandour K; Radovanovic D; Shy RR; Krajewski KM; Shy ME; Nicholson GA
    Arch Neurol; 2007 Jul; 64(7):974-8. PubMed ID: 17620487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset hereditary axonal neuropathies.
    Bennett CL; Lawson VH; Brickell KL; Isaacs K; Seltzer W; Lipe HP; Weiss MD; Carter GT; Flanigan KM; Chance PF; Bird TD
    Neurology; 2008 Jul; 71(1):14-20. PubMed ID: 18495953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the phenotypic manifestations of MFN2 R104W mutation in Charcot-Marie-Tooth type 2.
    Genari AB; Borghetti VH; Gouvêa SP; Bueno KC; dos Santos PL; dos Santos AC; Barreira AA; Lourenço CM; Marques W
    Neuromuscul Disord; 2011 Jun; 21(6):428-32. PubMed ID: 21531138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease: role of a single hit?
    Hedrich K; Hagenah J; Djarmati A; Hiller A; Lohnau T; Lasek K; Grünewald A; Hilker R; Steinlechner S; Boston H; Kock N; Schneider-Gold C; Kress W; Siebner H; Binkofski F; Lencer R; Münchau A; Klein C
    Arch Neurol; 2006 Jun; 63(6):833-8. PubMed ID: 16769864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurofilament light chain gene (NEFL) mutation Pro22Ser can be associated with mixed axonal and demyelinating neuropathy.
    Bhagavati S; Maccabee PJ; Xu W
    J Clin Neurosci; 2009 Jun; 16(6):830-1. PubMed ID: 19286384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital hypomyelinating neuropathy, a long term follow-up study in an affected family.
    Smit LS; Roofthooft D; van Ruissen F; Baas F; van Doorn PA
    Neuromuscul Disord; 2008 Jan; 18(1):59-62. PubMed ID: 17825553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2.
    Verhoeven K; Claeys KG; Züchner S; Schröder JM; Weis J; Ceuterick C; Jordanova A; Nelis E; De Vriendt E; Van Hul M; Seeman P; Mazanec R; Saifi GM; Szigeti K; Mancias P; Butler IJ; Kochanski A; Ryniewicz B; De Bleecker J; Van den Bergh P; Verellen C; Van Coster R; Goemans N; Auer-Grumbach M; Robberecht W; Milic Rasic V; Nevo Y; Tournev I; Guergueltcheva V; Roelens F; Vieregge P; Vinci P; Moreno MT; Christen HJ; Shy ME; Lupski JR; Vance JM; De Jonghe P; Timmerman V
    Brain; 2006 Aug; 129(Pt 8):2093-102. PubMed ID: 16714318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations.
    Detmer SA; Chan DC
    J Cell Biol; 2007 Feb; 176(4):405-14. PubMed ID: 17296794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.